Cargando…
Biomarkers for site-specific response to neoadjuvant chemotherapy in epithelial ovarian cancer: relating MRI changes to tumour cell load and necrosis
BACKGROUND: Diffusion-weighted magnetic resonance imaging (DW-MRI) potentially interrogates site-specific response to neoadjuvant chemotherapy (NAC) in epithelial ovarian cancer (EOC). METHODS: Participants with newly diagnosed EOC due for platinum-based chemotherapy and interval debulking surgery w...
Autores principales: | Winfield, Jessica M., Wakefield, Jennifer C., Brenton, James D., AbdulJabbar, Khalid, Savio, Antonella, Freeman, Susan, Pace, Erika, Lutchman-Singh, Kerryn, Vroobel, Katherine M., Yuan, Yinyin, Banerjee, Susana, Porta, Nuria, Ahmed Raza, Shan E., deSouza, Nandita M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961011/ https://www.ncbi.nlm.nih.gov/pubmed/33398064 http://dx.doi.org/10.1038/s41416-020-01217-5 |
Ejemplares similares
-
Modelling DW-MRI data from primary and metastatic ovarian tumours
por: Winfield, Jessica M., et al.
Publicado: (2015) -
DCE-MRI, DW-MRI, and MRS in Cancer: Challenges and Advantages of Implementing Qualitative and Quantitative Multi-parametric Imaging in the Clinic
por: Winfield, Jessica M., et al.
Publicado: (2016) -
Loop-Mediated Isothermal Amplification Assay for Detecting Tumor Markers and Human Papillomavirus: Accuracy and Supplemental Diagnostic Value to Endovaginal MRI in Cervical Cancer
por: Wormald, Benjamin, et al.
Publicado: (2021) -
ATARI trial: ATR inhibitor in combination with olaparib in gynecological cancers with ARID1A loss or no loss (ENGOT/GYN1/NCRI)
por: Banerjee, Susana, et al.
Publicado: (2021) -
Lab-on-chip assay of tumour markers and human papilloma virus for cervical cancer detection at the point-of-care
por: Wormald, Benjamin W., et al.
Publicado: (2022)